Bleeding Risk in Nonvalvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies

Introduction  In randomized trials in atrial fibrillation (AF) patients on direct oral anticoagulants (DOACs) have a lower risk of bleeding compared with warfarin. However, data from randomized trials may not extrapolate to general population. We aimed to determine the risk of bleeding in patients o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yimin Pearl, Kehar, Rohan, Iansavitchene, Alla, Lazo-Langner, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358046/
https://www.ncbi.nlm.nih.gov/pubmed/32676543
http://dx.doi.org/10.1055/s-0040-1714918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358046/
https://www.ncbi.nlm.nih.gov/pubmed/32676543
http://dx.doi.org/10.1055/s-0040-1714918

Ejemplares similares